BBV154 – UPSC PrelimsBy IAS4Sure / February 11, 2022 BBV154: BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. It is the first Intranasal Covid-19 Vaccine being developed by Bharat Biotech.